, Singapore

Daily Markets Briefing: STI down 0%

Don't expect gains today.

The Straits Times Index (STI) ended 0.12 or 0% lower at 3,183.14.

The top active stocks were DBS, which fell 1.2%, OCBC Bank, which dipped 0.63%, UOB, which went down 1.21%, Genting Sing, which slipped 0.57%, and Singtel, which remained unchanged.

The FTSE Mid Cap grew 0.02% whilst the FTSE Small Cap rose 0.44%.

According to OCBC Investment Research (OIR), US stocks finished lower Wednesday as lingering trade woes overshadowed the release of the minutes from the Federal Reserve’s policy meeting that was largely interpreted as accommodative.

Six out of eleven S&P 500 industries ended lower. The best performers were Utilities (0.81%) and Health Care (0.63%) whilst worst performers were Energy (-1.58%) and Consumer Discretionary (-0.90%). 

“The STI is likely to track the losses on Wall Street overnight amidst trade tensions,” OIR said. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare